Sonoma Pharmaceuticals
SNOA
#11061
Rank
โ‚ฌ4.83 M
Marketcap
1,01ย โ‚ฌ
Share price
1.80%
Change (1 day)
-70.62%
Change (1 year)

EPS for Sonoma Pharmaceuticals (SNOA)

EPS in 2026 (TTM): -1,40ย โ‚ฌ

According to Sonoma Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,48ย โ‚ฌ. In 2018 the company made an earnings per share (EPS) of -351,56ย โ‚ฌ an increase over its 2017 EPS that were of -449,02ย โ‚ฌ.

EPS history for Sonoma Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,40ย โ‚ฌ
2018-351,56ย โ‚ฌ-21.7%
2017-449,02ย โ‚ฌ-241.62%
2016317,05ย โ‚ฌ-170.36%
2015-450,63ย โ‚ฌ-354.55%
2014177,03ย โ‚ฌ-122.01%
2013-804,37ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-0,08047ย โ‚ฌ-94.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-0,85ย โ‚ฌ-42.42%๐Ÿ‡บ๐Ÿ‡ธ USA